Overview

Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this trial is to investigate the effect of early treatment of glucose toxicity with acarbose, a drug to control postprandial hyperglycemia, on the occurence of cardiovascular events and the inhibition of atherosclerosis.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Aichi Gakuin University
Treatments:
Acarbose
Criteria
Inclusion Criteria:

- Patients who have been diagnosed with coronary artery disease, with type 2 diabetes or
impaired glucose tolerance

Exclusion Criteria:

- Patients scheduled to undergo revascularization at the time of enrollment

- Patients who are being treated with an oral hypoglycemic drug or an insulin
preparation

- Patients with a history of laparotomy of ileus

- Pre- and postoperative patients or individuals with severe infection or serious trauma

- Patients with gastrointestinal disorders such as diarrhea and vomiting

- Patients with a history of hypersensitivity to acarbose

- Pregnant or possibly pregnant women

- Patients who are judged by the attending physician to be otherwise ineligible